Metabolic syndrome: definitions and controversies

Kassi, Eva; Pervanidou, Panagiota; Kaltsas, Gregory; Chrousos, George
January 2011
BMC Medicine;2011, Vol. 9 Issue 1, p48
Academic Journal
Metabolic syndrome (MetS) is a complex disorder defined by a cluster of interconnected factors that increase the risk of cardiovascular atherosclerotic diseases and diabetes mellitus type 2. Currently, several different definitions of MetS exist, causing substantial confusion as to whether they identify the same individuals or represent a surrogate of risk factors. Recently, a number of other factors besides those traditionally used to define MetS that are also linked to the syndrome have been identified. In this review, we critically consider existing definitions and evolving information, and conclude that there is still a need to develop uniform criteria to define MetS, so as to enable comparisons between different studies and to better identify patients at risk. As the application of the MetS model has not been fully validated in children and adolescents as yet, and because of its alarmingly increasing prevalence in this population, we suggest that diagnosis, prevention and treatment in this age group should better focus on established risk factors rather than the diagnosis of MetS.


Related Articles

  • MetS and cardiovascular risk factors among Palestinians of East Jerusalem. Sham'a, R. A. H. Abu; Darwazah, A. K.; Kufri, F. H.; Yassin, I. H.; Torok, N. I. // Eastern Mediterranean Health Journal;nov/dic2009, Vol. 15 Issue 6, p1464 

    In a cross-sectional survey conducted in 2005, we determined the prevalence metabolic syndrome (MetS) and other atherosclerotic cardiovascular disease risk factors among a sample of 342 Palestinians ≥ 20 years in East Jerusalem. Participants were interviewed and anthropometric measurements...

  • Metabolic Syndrome, Prediabetes, and Brain Abnormalities onMRI in Patients With Manifest Arterial Disease: The SMART-MR Study. Tiehuis, Audrey M.; van der Graaf, Yolanda; Mali, Willem P. T. M.; Vincken, Koen; Muller, Majon; Geerlings, Mirjam I. // Diabetes Care;Sep2014, Vol. 37 Issue 9, p2515 

    OBJECTIVE: Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors leading to atherosclerosis and diabetes. Diabetes is associated with both structural and functional abnormalities of the brain. MetS, even before diabetes is diagnosed, may also predispose to cerebral changes,...

  • Effects of rs7903146 Variation in the Tcf7l2 Gene in the Lipid Metabolism of Three Different Populations. Perez-Martinez, Pablo; Perez-Caballero, Ana I.; Garcia-Rios, Antonio; Yubero-Serrano, Elena M.; Camargo, Antonio; Gomez-Luna, Maria J.; Marin, Carmen; Gomez-Luna, Purificacion; Dembinska-Kiec, Aldona; Rodriguez-Cantalejo, Fernando; Tinahones, Francisco J.; Roche, Helen M.; Perez-Jimenez, Francisco; Lopez-Miranda, Jose; Delgado-Lista, Javier; Clarke, Robert // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Background: TCF7L2 rs7903146 is an important genetic factor predicting type 2 diabetes (T2DM) which has also been linked to higher cardiovascular risk. To date, there is little information about the additional impact of this single nucleotide polymorphism (SNP) beyond glucose metabolism....

  • Nutrapharmacology of Tocotrienols for Metabolic Syndrome. Weng-Yew, Wong; Brown, Lindsay // Current Pharmaceutical Design;7/11/2011, Vol. 17 Issue 21, p2206 

    Metabolic syndrome is defined as a set of health risk factors that are associated with an increased chance of cardiovascular diseases and type 2 diabetes. These include abdominal obesity, hyperglycemia, impaired glucose tolerance, dyslipidemia, and hypertension. Interventions in metabolic...

  • Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists? Ahmed, Mohamed H.; Barakat, Salma; Almobarak, Ahmed O. // Journal of Obesity;2012, Vol. 2012, p1 

    Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome and type 2 diabetes and is present in up to one-third of the general population. Evidence is now accumulating that NAFLD is associated with obesity and diabetes and may serve as a predictor of...

  • Metabolic syndrome in the Middle East. Sliem, Hamdy Ahmed; Ahmed, Seham; Nemr, Nader; El-Sherif, Iman // Indian Journal of Endocrinology & Metabolism;Jan2012, Vol. 16 Issue 1, p67 

    Metabolic syndrome (MS) is a combination of medical disorders that, in concert, increase the risk of developing cardiovascular disease and diabetes. It affects about one in four people in the Middle East, and prevalence increases with age. The aim of current review is to discuss the prevalence...

  • The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. FEDERICO, A.; DALLIO, M.; MASARONE, M.; PERSICO, M.; LOGUERCIO, C. // European Review for Medical & Pharmacological Sciences;Nov2016, Vol. 20 Issue 22, p4731 

    The non-alcoholic fatty liver disease is considered a predominant hepatopathy worldwide and a component of metabolic syndrome. It represents a risk factor for the development of cardiovascular diseases, independently of the presence of diabetes mellitus, hypertension and obesity. For this...

  • Guideline-Driven Intervention on SCI-Associated Dyslipidemia, Metabolic Syndrome, and Glucose Intolerance Using Pharmacological Agents. Ronald Goldberg // Topics in Spinal Cord Injury Rehabilitation;Jan2009, Vol. 14 Issue 3, p46 

    This review summarizes current thinking and evidence-based recommendations for pharmacotherapy in the treatment of dyslipidemia, metabolic syndrome, and glucose intolerance as a basis for their application to individuals with a spinal cord injury (SCI). Although the evidence that subjects with...

  • Psychological Recovery in the Metabolic Syndrome in the Context of Antioxidant Therapy -Case Presentation. AVRAM, Gică; DUMITRESCU, Ana-Maria; WELDON, Richard; BOTEZ, Corneliu; GHIURU, Rodica // Annals of Philosophy, Social & Human Disciplines;2015, Vol. 1, p105 

    Representing a major medical issue, especially in industrialized countries, the metabolic syndrome (MetS) consists of a complex association of the most dangerous metabolic and cardiovascular risk factors according to the International Diabetes Federation: diabetes and prediabetes, abdominal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics